Stryker Research and Development Expenses 2010-2023 | SYK
Stryker annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Stryker research and development expenses for the quarter ending December 31, 2023 were $0.350B, a 7.36% increase year-over-year.
- Stryker research and development expenses for the twelve months ending December 31, 2023 were $1.388B, a 4.54% decline year-over-year.
- Stryker annual research and development expenses for 2023 were $1.388B, a 4.54% decline from 2022.
- Stryker annual research and development expenses for 2022 were $1.454B, a 17.73% increase from 2021.
- Stryker annual research and development expenses for 2021 were $1.235B, a 25.51% increase from 2020.
| Stryker Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $1,388 |
| 2022 | $1,454 |
| 2021 | $1,235 |
| 2020 | $984 |
| 2019 | $971 |
| 2018 | $862 |
| 2017 | $787 |
| 2016 | $715 |
| 2015 | $625 |
| 2014 | $614 |
| 2013 | $536 |
| 2012 | $471 |
| 2011 | $462 |
| 2010 | $394 |
| 2009 | $336 |
| Stryker Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $350 |
| 2023-09-30 | $353 |
| 2023-06-30 | $346 |
| 2023-03-31 | $339 |
| 2022-12-31 | $326 |
| 2022-09-30 | $364 |
| 2022-06-30 | $351 |
| 2022-03-31 | $413 |
| 2021-12-31 | $331 |
| 2021-09-30 | $306 |
| 2021-06-30 | $310 |
| 2021-03-31 | $288 |
| 2020-12-31 | $255 |
| 2020-09-30 | $242 |
| 2020-06-30 | $233 |
| 2020-03-31 | $254 |
| 2019-12-31 | $254 |
| 2019-09-30 | $246 |
| 2019-06-30 | $246 |
| 2019-03-31 | $225 |
| 2018-12-31 | $221 |
| 2018-09-30 | $221 |
| 2018-06-30 | $216 |
| 2018-03-31 | $204 |
| 2017-12-31 | $205 |
| 2017-09-30 | $198 |
| 2017-06-30 | $192 |
| 2017-03-31 | $192 |
| 2016-12-31 | $189 |
| 2016-09-30 | $184 |
| 2016-06-30 | $183 |
| 2016-03-31 | $159 |
| 2015-12-31 | $164 |
| 2015-09-30 | $155 |
| 2015-06-30 | $154 |
| 2015-03-31 | $152 |
| 2014-12-31 | $153 |
| 2014-09-30 | $153 |
| 2014-06-30 | $158 |
| 2014-03-31 | $150 |
| 2013-12-31 | $139 |
| 2013-09-30 | $136 |
| 2013-06-30 | $132 |
| 2013-03-31 | $129 |
| 2012-12-31 | $129 |
| 2012-09-30 | $114 |
| 2012-06-30 | $116 |
| 2012-03-31 | $112 |
| 2011-12-31 | $115 |
| 2011-09-30 | $122 |
| 2011-06-30 | $114 |
| 2011-03-31 | $111 |
| 2010-12-31 | $110 |
| 2010-09-30 | $99 |
| 2010-06-30 | $95 |
| 2010-03-31 | $90 |
| 2009-12-31 | $89 |
| 2009-09-30 | $84 |
| 2009-06-30 | $83 |
| 2009-03-31 | $80 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $127.423B | $20.498B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.688B | 24.51 |
| Medtronic (MDT) | Ireland | $107.939B | 15.28 |
| Boston Scientific (BSX) | United States | $101.215B | 33.65 |
| EssilorLuxottica (ESLOY) | France | $99.656B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.872B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 30.04 |
| ResMed (RMD) | United States | $27.097B | 27.09 |
| Terumo (TRUMY) | Japan | $25.416B | 35.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.968B | 16.07 |
| Baxter (BAX) | United States | $20.831B | 15.19 |
| Koninklijke Philips (PHG) | Netherlands | $19.511B | 15.56 |
| Insulet (PODD) | United States | $11.713B | 61.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.842B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.136B | 24.24 |
| BellRing Brands (BRBR) | United States | $7.357B | 39.56 |
| Lantheus Holdings (LNTH) | United States | $4.415B | 11.40 |
| Haemonetics (HAE) | United States | $4.320B | 22.10 |
| Perrigo (PRGO) | Ireland | $4.132B | 11.82 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.536B | 16.72 |
| Envista Holdings (NVST) | United States | $3.475B | 13.22 |
| QuidelOrtho (QDEL) | United States | $2.702B | 9.81 |
| Neogen (NEOG) | United States | $2.666B | 25.65 |
| Green Thumb Industries (GTBIF) | United States | $2.566B | 81.33 |
| ICU Medical (ICUI) | United States | $2.382B | 17.77 |
| TG Therapeutics (TGTX) | United States | $2.202B | 712.50 |
| Owens & Minor (OMI) | United States | $1.959B | 18.80 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.941B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.788B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.662B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.475B | 45.95 |
| InMode (INMD) | Israel | $1.459B | 7.55 |
| LeMaitre Vascular (LMAT) | United States | $1.442B | 47.58 |
| Warby Parker (WRBY) | United States | $1.318B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.81 |
| AtriCure (ATRC) | United States | $1.121B | 0.00 |
| MacroGenics (MGNX) | United States | $1.015B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.905B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.701B | 15.15 |
| Cresco Labs (CRLBF) | United States | $0.695B | 0.00 |
| Evolus (EOLS) | United States | $0.678B | 0.00 |
| Quanterix (QTRX) | United States | $0.616B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.551B | 11.94 |
| Jin Medical (ZJYL) | China | $0.543B | 0.00 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.492B | 0.00 |
| PetIQ (PETQ) | United States | $0.489B | 18.24 |
| ZimVie (ZIMV) | United States | $0.437B | 26.75 |
| OraSure Technologies (OSUR) | United States | $0.423B | 7.00 |
| Biote (BTMD) | United States | $0.415B | 3.95 |
| Aurora Cannabis (ACB) | Canada | $0.405B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 41.42 |
| Zynex (ZYXI) | United States | $0.362B | 41.70 |
| Viemed Healthcare (VMD) | United States | $0.312B | 31.00 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.273B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.242B | 14.78 |
| Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.191B | 0.00 |
| Veru (VERU) | United States | $0.187B | 0.00 |
| Omeros (OMER) | United States | $0.179B | 0.00 |
| High Tide (HITI) | Canada | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.164B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.152B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.132B | 66.41 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.70 |
| InterCure (INCR) | Israel | $0.118B | 20.00 |
| Fonar (FONR) | United States | $0.101B | 8.70 |
| Cellectar Biosciences (CLRB) | United States | $0.100B | 0.00 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.086B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| Brainsway (BWAY) | Israel | $0.082B | 0.00 |
| Safety Shot (SHOT) | United States | $0.080B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.04 |
| Zevia PBC (ZVIA) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.54 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.020B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 75.27 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |